Clinical Trials Browser

Withdrawn × Lymphoma × Nelfinavir × Clear all

NCT03422874 2018-02-06

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Phase 1 Withdrawn

Lymphoma, Neoplasms